News
‘Can it actually deliver?’: Why Big Pharma is making the leap to the quantum realm
Overview
Artificial intelligence has long been seen as a way to supercharge drug development. But a whole new frontier of computing is opening up at cutting-edge labs around the globe—and Big Pharmas are getting in on the action.
The Big Picture
New York is both a major biopharma hub and hosts the world’s leading quantum hardware company. The article’s core thesis — that pharma-quantum partnerships are accelerating — amplifies New York’s position as a hub where both sides of this equation already coexist.
